Source link : https://newshealth.biz/health-news/fda-oks-perioperative-immunotherapy-for-stomach-cancer/
(MedPage Today) — The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable gastric or gastroesophageal junction cancer, the agency announced on Tuesday. Approval stipulates use of… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/118746 Author : Publish date : 2025-11-26 17:46:00 Copyright for syndicated content belongs to the linked Source.
The post FDA OKs Perioperative Immunotherapy for Stomach Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-26 17:46:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8